Intas Pharmaceuticals in collaboration with its global Accord brand subsidiaries, has acquired UDENYCA (pegfilgrastim-cbqv) ...

Minghui Pharmaceutical ( Minghui ), a late-stage clinical biopharmaceutical company, announced the closing of a $131 million ...

Modeyso is the first and only treatment option approved by the FDA for this ultra-rare and aggressive brain tumor that affects an estimated 2,000 people in the U.S. each year, many of whom are ...

Emerging therapies targeting GD2, a marker highly expressed in neuroblastoma, offer tremendous promise. FDA-approved ...

Advarra, a provider of clinical research technology, expanded its Study Collaboration, a study startup technology designed to ...

Founded in 1997, VEG built its reputation through its deep engineering expertise across a range of CQV services. The ...

The expansion increases output, enhancing Axplora’s ability to meet growing global demand for high-value pharmaceutical ...

Buildout includes Gerteis Macro-Pactor install to meet growing demand for complex oral solid dose development and manufacturing.

Stamoulis joins Mallinckrodt from Incyte, a leading biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. In addition ...

Former Vice President and Global Head of Commercial Development of Lonza’s small molecules custom manufacturing business to head up Arcinova.

Marken's Mike Bartone, VP of Global Cold Chain Solutions Management, on scaling temperature-controlled precision logistics, ...

The Vibativ 4-Vial Starter Pak is an FDA-approved injectable antibiotic indicated to treat HABP/VABP and complicated skin and ...